GSID - ETF AI Analysis
Top Page
Goldman Sachs MarketBeta International Equity ETF (GSID)
Rating:66Neutral
Price Target:―
Positive Factors
Strong Year-To-Date Performance
The ETF has delivered strong gains so far this year, showing solid momentum for investors.
Leading International Holdings
Several top positions, including ASML, HSBC, BHP, and other major global companies, have shown strong performance and help drive the fund’s returns.
Broad Global and Sector Diversification
The fund spreads its investments across many countries and industries, which helps reduce the impact of problems in any single market or sector.
Negative Factors
Recent Short-Term Weakness
The ETF’s performance over the last month has been weak, which may signal short-term volatility or a pause in its upward trend.
Exposure to Underperforming Holding
AstraZeneca, one of the top holdings, has been lagging this year, slightly weighing on the overall portfolio.
Concentration in Japan and Financials
A large share of the fund is invested in Japanese stocks and financial companies, which could increase risk if those areas face a downturn.
GSID vs. SPDR S&P 500 ETF (SPY)
AUM971.23M
RegionDeveloped Markets
Expense Ratio0.20%
Beta0.74
IssuerGoldman Sachs
Inception DateMay 12, 2020
Dividend Yield2.53%
Asset ClassEquity
Index TrackedSolactive GBS Developed Markets ex North America Large & Mid Cap Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume58,548
30 Day Avg. Volume62,233
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
88.96Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering882
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GSID Summary
GSID, the Goldman Sachs MarketBeta International Equity ETF, tracks the Solactive GBS Developed Markets ex North America Large & Mid Cap Index. That means it invests in many large and mid-sized companies outside the U.S. and Canada, across countries like Japan, the UK, Germany, and Australia. Its holdings include well-known names such as Nestlé and HSBC, along with firms in financials, industrials, health care, and more. Someone might invest in GSID to diversify their portfolio internationally and spread risk across many companies and sectors. A key risk is that international stock prices can go up and down with global markets and currency swings.
How much will it cost me?The Goldman Sachs MarketBeta International Equity ETF (GSID) has an expense ratio of 0.20%, which means you’ll pay $2 per year for every $1,000 invested. This is lower than average for ETFs because it is passively managed, tracking an index rather than relying on active management strategies.
What would affect this ETF?Positive drivers for GSID could include strong growth in developed markets outside North America, particularly in sectors like financials and industrials, which make up a significant portion of the ETF's holdings. However, negative factors such as rising interest rates or economic slowdowns in these regions could impact corporate earnings and investor sentiment, especially for top holdings like ASML and Nestlé. Additionally, regulatory changes in key countries or global trade tensions could create uncertainty for the ETF's performance.
GSID Top 10 Holdings
GSID leans heavily into Europe and Japan, with a clear tilt toward global blue chips rather than flashy growth names. ASML is the star of the show, its strong year-to-date run giving the fund a powerful semiconductor engine, even if recent months have been choppy. Financials like HSBC and Mitsubishi UFJ are steadily adding fuel, helped by firmer rate environments abroad. On the defensive side, Nestlé and Roche have been more mixed, acting like ballast rather than boosters. Overall, performance is driven by a handful of rising giants in a broadly diversified, developed-markets mix.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.10% | $29.96M | €611.79B | 91.13% | 76 Outperform | |
| HSBC Holdings | 1.46% | $14.08M | £239.17B | 40.44% | 80 Outperform | |
| Roche Holding AG | 1.39% | $13.43M | $344.30B | 21.61% | 73 Outperform | |
| Shell (UK) | 1.28% | $12.40M | £216.18B | 40.71% | 73 Outperform | |
| Novartis AG | 1.19% | $11.52M | CHF218.02B | 13.47% | 80 Outperform | |
| Mitsubishi UFJ Financial Group | 1.14% | $10.99M | ¥38.71T | 52.68% | 76 Outperform | |
| AstraZeneca | 1.07% | $10.40M | $246.54B | -6.13% | 80 Outperform | |
| Nestlé SA | 1.06% | $10.30M | CHF195.59B | -0.68% | 71 Outperform | |
| Siemens | 1.00% | $9.72M | €207.41B | 8.00% | 74 Outperform | |
| SAP SE | 0.99% | $9.57M | €223.54B | -17.36% | 66 Neutral |
GSID Technical Analysis
Negative
―
Price Trends
76.62
Negative
75.52
Negative
73.37
Positive
Market Momentum
-0.63
Positive
39.10
Neutral
34.82
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GSID, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 75.32, equal to the 50-day MA of 76.62, and equal to the 200-day MA of 73.37, indicating a neutral trend. The MACD of -0.63 indicates Positive momentum. The RSI at 39.10 is Neutral, neither overbought nor oversold. The STOCH value of 34.82 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GSID.
GSID Peer Comparison
Comparison Results
Performance Comparison
GSID
Goldman Sachs MarketBeta International Equity ETF
74.68
9.90
15.28%
JHMD
John Hancock Multifactor Developed International ETF
―
―
―
NUDM
Nuveen ESG International Developed Markets Equity ETF
―
―
―
IQDG
WisdomTree International Quality Dividend Growth Fund
―
―
―
DWM
WisdomTree International Equity Fund
―
―
―
EFAX
SPDR MSCI EAFE Fossil Fuel Free ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents